Metformin effective for prevention of clozapine-induced weight gain: study

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-06-29 05:15 GMT   |   Update On 2022-06-29 05:20 GMT
Advertisement

Metformin is effective for the prevention of clozapine-induced weight gain according to a recent study published in the Acta Psychiatrica Scandinavica

Clozapine is presently the sole antipsychotic with an indication for treatment-resistant Schizophrenia but is associated with significant weight gain and other metabolic aberrations. This retrospective chart review aimed to evaluate the effectiveness of adjunctive metformin in preventing clozapine-induced weight gain.

Advertisement

They conducted a retrospective chart review of patients newly initiated on clozapine at the Centre for Addiction and Mental Health in Canada, from November 2014 to April 2021. Our primary outcome was body weight at 6 and 12 months after clozapine initiation. Other metabolic parameters served as secondary outcomes.

Results

  • Among 396 patients (males: 71.5%, mean age: 42.8 years) initiated on clozapine, 69 were on metformin or prescribed it ≤3 months after clozapine initiation.
  • The clozapine+metformin group demonstrated less weight gain compared with the clozapine-only group at 6 months and 12 months after clozapine initiation
  • Adaptive changes were also observed for fasting glucose and triglycerides in the clozapine+metformin group compared with clozapine only.

In this large retrospective naturalistic cohort study, co-prescription of clozapine and metformin was associated with less weight gain and related metabolic dysfunction at 6 and 12 months after initiation versus clozapine alone. These findings provide evidence for the effectiveness of metformin in preventing clozapine-induced weight gain; larger randomized controlled trials are needed to confirm these results.

Reference:

Stogios N, Maksyutynska K, Navagnanavel J, et al. Metformin for the prevention of clozapine-induced weight gain: A retrospective naturalistic cohort study. Acta Psychiatrica Scandinavica.

DOI: 10.1111/acps.13462.

Keywords:

Stogios N, Maksyutynska K, Navagnanavel J, Metformin, prevention, clozapine, induced, weight, gain, retrospective, naturalistic, cohort, study, Acta, Psychiatrica, Scandinavica, Nicolette Stogios,Kateryna Maksyutynska,Janani Navagnanavel,Marcos Sanches,Valerie Powell,Philip Gerretsen,Ariel Graff-Guerrero,Araba F. Chintoh,George Foussias,Gary Remington,Margaret K. Hahn,Sri Mahavir Agarwal


Tags:    
Article Source : Acta Psychiatrica Scandinavica

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News